8
Views
0
CrossRef citations to date
0
Altmetric
Review

Role of lasers in the treatment of benign pigmented lesions

&
Pages 663-670 | Published online: 10 Jan 2014

References

  • Goldman L, Wilson RG, Hornby P, Meyer RG. Radiation from a Q-Switched ruby laser. Effect of repeated impacts of power output of 10 megawatts on a tattoo of man. J. Invest. Dermatol.44, 69–71 (1965).
  • Anderson RR, Parrish JA. The optics of human skin. J. Invest. Dermatol.77, 13–19 (1981).
  • Nelson JS, Applebaum J. Treatment of superficial cutaneous pigmented lesions by melanin-specific selective photothermolysis using the Q-switched ruby laser. Ann. Plast. Surg.29, 231–237 (1992).
  • Goldberg DJ. Benign pigmented lesions of the skin. Treatment with the Q-switched ruby laser. J. Dermatol. Surg. Oncol.19, 376–379 (1993).
  • Jang KA, Chung EC, Choi JH, Sung KJ, Moon KC, Koh JK. Successful removal of freckles in Asian skin with a Q-switched alexandrite laser. Dermatol. Surg.26(3), 231–234 (2000).
  • Rashid T, Hussain I, Haider M, Haroon TS. Laser therapy of freckles and lentigines with quasi-continuous, frequency-doubled, Nd:YAG (532 nm) laser in Fitzpatrick skin type IV: a 24-month follow-up. J. Cosmet. Laser Ther.4, 81–85 (2002).
  • Huang YL, Liao YL, Lee SH, Hong HS. Intense pulsed light for the treatment of facial freckles in Asian skin. Dermatol. Surg.28, 1007–1012 (2002).
  • Wang CC, Sue YM, Yang CH, Chen CK. A comparison of Q-switched alexandrite laser and intense pulsed light for the treatment of freckles and lentigines in Asian persons: a randomized, physician-blinded, split-face comparative trial. J. Am. Acad. Dermatol.54, 804–810 (2006).
  • Kopera D, Hohenleutner U, Landthaler M. Quality-switched ruby laser treatment of solar lentigines and Becker’s nevus: a histopathological and immunohistochemical study. Dermatology194, 338–343 (1997).
  • Kilmer SL, Wheeland RG, Goldberg DJ, Anderson RR. Treatment of epidermal pigmented lesions with the frequency-doubled Q-switched Nd:YAG laser. A controlled, single-impact, dose-response, multicenter trial. Arch. Dermatol.130, 1515–1519 (1994).
  • Tse Y, Levine VJ, McClain SA, Ashinoff R. The removal of cutaneous pigmented lesions with the Q-switched ruby laser and the Q-switched neodymium: yttrium-aluminum-garnet laser. A comparative study. J. Dermatol. Surg. Oncol.20, 795–800 (1994).
  • Stern RS, Dover JS, Levin JA, Arndt KA. Laser therapy versus cryotherapy of lentigines: a comparative trial. J. Am. Acad. Dermatol.30, 985–987 (1994).
  • Todd MM, Rallis TM, Gerwels JW, Hata TR. A comparison of 3 lasers and liquid nitrogen in the treatment of solar lentigines: a randomized, controlled, comparative trial. Arch. Dermatol.136, 841–846 (2000).
  • Kono T, Manstein D, Chan HH, Nozaki M, Anderson RR. Q-switched ruby versus long-pulsed dye laser delivered with compression for treatment of facial lentigines in Asians. Lasers Surg. Med.38, 94–97 (2006).
  • Shimbashi T, Kamide R, Hashimoto T. Long-term follow-up in treatment of solar lentigo and cafe-au-lait macules with Q-switched ruby laser. Aesthetic Plast. Surg.21, 445–448 (1997).
  • Grossman MC, Anderson RR, Farinelli W, Flotte TJ, Grevelink JM. Treatment of cafe au lait macules with lasers. A clinicopathologic correlation. Arch. Dermatol.131, 1416–1420 (1995).
  • Somyos K, Boonchu K, Somsak K, Panadda L, Leopairut J. Copper vapour laser treatment of cafe-au-lait macules. Br. J. Dermatol.135, 964–968 (1996).
  • Alster TS. Complete elimination of large cafe-au-lait birthmarks by the 510-nm pulsed dye laser. Plast. Reconstr. Surg.96, 1660–1664 (1995).
  • Alster TS, Williams CM. Cafe-au-lait macule in type V skin: successful treatment with a 510 nm pulsed dye laser. J. Am. Acad. Dermatol.33, 1042–1043 (1995).
  • Tan OT, Morelli JG, Kurban AK. Pulsed dye laser treatment of benign cutaneous pigmented lesions. Lasers Surg. Med.12, 538–542 (1992).
  • Cox NH, Malcolm A, Long ED. Superficial spreading melanoma and blue naevus within naevus spilus – ultrastructural assessment of giant pigment granules. Dermatology194, 213–216 (1997).
  • Grevelink JM, Gonzalez S, Bonoan R, Vibhagool C, Gonzalez E. Treatment of nevus spilus with the Q-switched ruby laser. Dermatol. Surg.23, 365–369 (1997).
  • Kagami S, Asahina A, Watanabe R, Mimura Y et al. Treatment of 153 Japanese patients with Q-switched alexandrite laser. Lasers Med Sci.22(3), 159–163 (2007).
  • Manaloto RM, Alster T. Erbium:YAG laser resurfacing for refractory melasma. Dermatol. Surg.25, 121–123 (1999).
  • Nouri K, Bowes L, Chartier T, Romagosa R, Spencer J. Combination treatment of melasma with pulsed CO2 laser followed by Q-switched alexandrite laser: a pilot study. Dermatol. Surg.25, 494–497 (1999).
  • Angsuwarangsee S, Polnikorn N. Combined ultrapulse CO2 laser and Q-switched alexandrite laser compared with Q-switched alexandrite laser alone for refractory melasma: split-face design. Dermatol. Surg.29, 59–64 (2003).
  • Wang CC, Hui CY, Sue YM, Wong WR, Hong HS. Intense pulsed light for the treatment of refractory melasma in Asian persons. Dermatol. Surg.30, 1196–1200 (2004).
  • Rokhsar CK, Fitzpatrick RE. The treatment of melasma with fractional photothermolysis: a pilot study. Dermatol. Surg.31, 1645–1650 (2005).
  • Trelles MA, Allones I, Moreno-Arias GA, Velez M. Becker’s naevus: a comparative study between erbium: YAG and Q-switched neodymium:YAG; clinical and histopathological findings. Br. J. Dermatol.152, 308–313 (2005).
  • Trelles MA, Allones I, Velez M, Moreno-Arias GA. Becker’s nevus: erbium: YAG versus Q-switched neodimium: YAG? Lasers Surg. Med.34, 295–297 (2004).
  • Waldorf HA, Kauvar AN, Geronemus RG. Treatment of small and medium congenital nevi with the Q-switched ruby laser. Arch. Dermatol.132, 301–304 (1996).
  • Grevelink JM, van Leeuwen RL, Anderson RR, Byers HR. Clinical and histological responses of congenital melanocytic nevi after single treatment with Q-switched lasers. Arch. Dermatol.133, 349–353 (1997).
  • Kono T, Ercocen AR, Chan HH, Kikuchi Y, Nozaki M. Effectiveness of the normal-mode ruby laser and the combined (normal-mode plus Q-switched) ruby laser in the treatment of congenital melanocytic nevi: a comparative study. Ann. Plast. Surg.49, 476–485 (2002).
  • Dave R, Mahaffey PJ. Combined early treatment of congenital melanocytic naevus with carbon dioxide and Nd:YAG lasers. Br. J. Plast. Surg.57, 720–724 (2004).
  • Kim S, Kang WH. Treatment of congenital nevi with the Q-switched Alexandrite laser. Eur. J. Dermatol.15, 92–96 (2005).
  • Chong SJ, Jeong E, Park HJ, Lee JY, Cho BK. Treatment of congenital nevomelanocytic nevi with the CO2 and Q-switched alexandrite lasers. Dermatol. Surg.31, 518–521 (2005).
  • Whang KK, Kim MJ, Song WK, Cho S. Comparative treatment of giant congenital melanocytic nevi with curettage or Er:YAG laser ablation alone versus with cultured epithelial autografts. Dermatol. Surg.31, 1660–1667 (2005).
  • Ostertag JU, Quaedvlieg PJ, Kerckhoffs FE, Vermeulen AH et al. Congenital naevi treated with erbium:YAG laser (Derma K) resurfacing in neonates: clinical results and review of the literature. Br. J. Dermatol.154, 889–895 (2006).
  • Vibhagool C, Byers HR, Grevelink JM. Treatment of small nevomelanocytic nevi with a Q-switched ruby laser. J. Am. Acad. Dermatol.36, 738–741 (1997).
  • Westerhof W, Gamei M. Treatment of acquired junctional melanocytic naevi by Q-switched and normal mode ruby laser. Br. J. Dermatol.148, 80–85 (2003).
  • Baba M, Bal N. Efficacy and safety of the short-pulse erbium:YAG laser in the treatment of acquired melanocytic nevi. Dermatol. Surg.32, 256–260 (2006).
  • Rosenbach A, Williams CM, Alster TS. Comparison of the Q-switched alexandrite (755 nm) and Q-switched Nd:YAG (1064 nm) lasers in the treatment of benign melanocytic nevi. Dermatol. Surg.23, 239–244 (1997).
  • Watanabe S, Takahashi H. Treatment of nevus of Ota with the Q-switched ruby laser. N. Engl. J. Med.29(331), 1745–1750 (1994).
  • Kono T, Chan HH, Ercocen AR et al. Use of Q-switched ruby laser in the treatment of nevus of Ota in different age groups. Lasers Surg. Med.32, 391–395 (2003).
  • Alster TS, Williams CM. Treatment of nevus of Ota by the Q-switched alexandrite laser. Dermatol. Surg.21, 592–596 (1995).
  • Wang HW, Liu YH, Zhang GK et al. Analysis of 602 Chinese cases of nevus of Ota and the treatment results treated by Q-switched alexandrite laser. Dermatol. Surg.33, 455–460 (2007).
  • Chan HH, King WW, Chan ES et al. In vivo trial comparing patients’ tolerance of Q-switched Alexandrite (QS Alex) and Q-switched neodymium:yttrium-aluminum-garnet (QS Nd:YAG) lasers in the treatment of nevus of Ota. Lasers Surg. Med.24, 24–28 (1999).
  • Chan HH, Ying SY, Ho WS, Kono T, King WW et al. An in vivo trial comparing the clinical efficacy and complications of Q-switched 755 nm alexandrite and Q-switched 1064 nm Nd:YAG lasers in the treatment of nevus of Ota. Dermatol. Surg.26, 919–922 (2000).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.